Johnson & Johnson (JNJ) Share buybacks
- Total buybacks · last 12 months (USD): Value $8.07B; Formula and calculation Trailing-year cash paid for share repurchases. Period ending 2026-06-28..
- Buyback yield · 12 months: Value (m); Formula and calculation Cash paid for share repurchases / current market cap. Period ending 2026-06-28..
Share buybacks
Overview →Financial period ending 2026-06-28; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total buybacks · last 12 months (USD) | $8.07B | Trailing-year cash paid for share repurchases. Period ending 2026-06-28. |
| Buyback yield · 12 months | (m) | Cash paid for share repurchases / current market cap. Period ending 2026-06-28. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Buybacks · 12 months | 8.07B USD | Payments for Repurchase of Common Stock |
| Market cap | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total buybacks | Market cap (USD) | Buyback yield |
|---|---|---|---|
| 2026-06-28 | $8.07B | (m) | (m) |
| 2026-03-29 | $7.85B | (m) | (m) |
| 2025-12-28 | $5.95B | (m) | (m) |
| 2025-09-28 | $4.31B | (m) | (m) |
| 2025-06-29 | $2.95B | (m) | (m) |
| 2025-03-30 | $3.08B | (m) | (m) |
| 2024-12-29 | $2.43B | (m) | (m) |
| 2024-09-29 | $2.37B | (m) | (m) |
| 2024-06-30 | $2.75B | (m) | (m) |
| 2024-03-31 | $2.99B | (m) | (m) |
| 2023-12-31 | $5.05B | (m) | (m) |
| 2023-10-01 | $6.16B | (m) | (m) |
| 2023-07-02 | $7.40B | (m) | (m) |
| 2023-04-02 | $8.00B | (m) | (m) |
| 2023-01-01 | $6.04B | (m) | (m) |
| 2022-10-02 | $5.71B | (m) | (m) |
| 2022-07-03 | $3.94B | (m) | (m) |
| 2022-04-03 | $3.60B | (m) | (m) |
| 2022-01-02 | $3.46B | (m) | (m) |
| 2021-10-03 | $2.78B | (m) | (m) |
| 2021-07-04 | $2.87B | (m) | (m) |
| 2021-04-04 | $2.95B | (m) | (m) |
| 2021-01-03 | $3.22B | (m) | (m) |
| 2020-09-27 | $3.33B | (m) | (m) |
| 2020-06-28 | $4.47B | (m) | (m) |
| 2020-03-29 | $6.25B | (m) | (m) |
| 2019-12-29 | $6.75B | (m) | (m) |
| 2019-09-29 | $10.13B | (m) | (m) |
| 2019-06-30 | $8.97B | (m) | (m) |
| 2019-03-31 | $6.63B | (m) | (m) |
| 2018-12-30 | $5.87B | (m) | (m) |
| 2018-09-30 | $2.88B | (m) | (m) |
| 2018-07-01 | $2.71B | (m) | (m) |
| 2018-04-01 | $4.46B | (m) | (m) |
| 2017-12-31 | $6.36B | (m) | (m) |
| 2017-10-01 | $7.57B | (m) | (m) |
| 2017-07-02 | $9.46B | (m) | (m) |
| 2017-04-02 | $9.93B | (m) | (m) |
| 2017-01-01 | $8.98B | (m) | (m) |
| 2016-10-02 | $8.85B | (m) | (m) |
| 2016-07-03 | $6.95B | (m) | (m) |
| 2016-04-03 | $5.48B | (m) | (m) |
| 2016-01-03 | $5.29B | (m) | (m) |
| 2015-09-27 | $6.14B | (m) | (m) |
| 2015-06-28 | $8.25B | (m) | (m) |
| 2015-03-29 | $8.55B | (m) | (m) |
| 2014-12-28 | $7.12B | (m) | (m) |
| 2014-09-28 | $4.87B | (m) | (m) |
| 2014-06-29 | $5.50B | (m) | (m) |
| 2014-03-30 | $4.31B | (m) | (m) |
| 2013-12-29 | $3.54B | (m) | (m) |
| 2013-09-29 | $3.05B | (m) | (m) |
| 2013-06-30 | $0.00 | (m) | (m) |
| 2013-03-31 | $12.85B | (m) | (m) |
| 2012-12-30 | $12.92B | (m) | (m) |
| 2012-09-30 | $13.77B | (m) | (m) |
| 2012-07-01 | $14.52B | (m) | (m) |
| 2012-04-01 | $2.16B | (m) | (m) |
| 2012-01-01 | $2.52B | (m) | (m) |
| 2011-10-02 | $2.96B | (m) | (m) |
| 2011-07-03 | $2.95B | (m) | (m) |
| 2011-04-03 | $2.85B | (m) | (m) |
| 2011-01-02 | $2.80B | (m) | (m) |
| 2010-10-03 | $2.47B | (m) | (m) |
| 2010-07-04 | $1.79B | (m) | (m) |
| 2010-04-04 | $1.68B | (m) | (m) |
| 2010-01-03 | $2.13B | (m) | (m) |
| 2009-09-27 | (m) | (m) | (m) |
| 2009-06-28 | (m) | (m) | (m) |
| 2009-03-29 | (m) | (m) | (m) |
| 2008-12-28 | $6.65B | (m) | (m) |
| 2008-09-28 | (m) | (m) | (m) |
| 2008-06-29 | (m) | (m) | (m) |
| 2007-12-30 | $5.61B | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |